Silo Pharma Inc
NASDAQ:SILO
Intrinsic Value
The intrinsic value of one SILO stock under the Base Case scenario is 0.025 USD. Compared to the current market price of 0.595 USD, Silo Pharma Inc is Overvalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Silo Pharma Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Silo Pharma Inc
Balance Sheet Decomposition
Silo Pharma Inc
Current Assets | 5.6m |
Cash & Short-Term Investments | 5.5m |
Other Current Assets | 152.7k |
Non-Current Assets | 295.8k |
Intangibles | 238.1k |
Other Non-Current Assets | 57.7k |
Free Cash Flow Analysis
Silo Pharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Silo Pharma Inc
Revenue
|
72.1k
USD
|
Cost of Revenue
|
-5.8k
USD
|
Gross Profit
|
66.3k
USD
|
Operating Expenses
|
-5m
USD
|
Operating Income
|
-4.9m
USD
|
Other Expenses
|
297.6k
USD
|
Net Income
|
-4.6m
USD
|
SILO Profitability Score
Profitability Due Diligence
Silo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Silo Pharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SILO Solvency Score
Solvency Due Diligence
Silo Pharma Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Silo Pharma Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SILO Price Targets Summary
Silo Pharma Inc
Dividends
Current shareholder yield for SILO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one SILO stock under the Base Case scenario is 0.025 USD.
Compared to the current market price of 0.595 USD, Silo Pharma Inc is Overvalued by 96%.